ES2855159T8 - Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización - Google Patents
Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolizaciónInfo
- Publication number
- ES2855159T8 ES2855159T8 ES11738401T ES11738401T ES2855159T8 ES 2855159 T8 ES2855159 T8 ES 2855159T8 ES 11738401 T ES11738401 T ES 11738401T ES 11738401 T ES11738401 T ES 11738401T ES 2855159 T8 ES2855159 T8 ES 2855159T8
- Authority
- ES
- Spain
- Prior art keywords
- aerosolization
- tobramycin
- administration
- treatment
- pulmonary infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36333010P | 2010-07-12 | 2010-07-12 | |
NO20101576 | 2010-11-08 | ||
PCT/EP2011/003405 WO2012007130A1 (en) | 2010-07-12 | 2011-07-08 | Treatment of lung infections by administration of tobramycin by aerolisation |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2855159T3 ES2855159T3 (es) | 2021-09-23 |
ES2855159T8 true ES2855159T8 (es) | 2022-01-04 |
Family
ID=45439015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11738401T Active ES2855159T3 (es) | 2010-07-12 | 2011-07-08 | Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización |
Country Status (12)
Country | Link |
---|---|
US (2) | US8598131B2 (es) |
EP (1) | EP2593110B1 (es) |
JP (1) | JP6000946B2 (es) |
KR (1) | KR102012418B1 (es) |
CN (2) | CN106074461A (es) |
AU (1) | AU2011278693B2 (es) |
BR (1) | BR112013000921A2 (es) |
CA (1) | CA2803187C (es) |
ES (1) | ES2855159T3 (es) |
MX (1) | MX336260B (es) |
RU (1) | RU2597842C2 (es) |
WO (1) | WO2012007130A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
MXPA05004580A (es) * | 2002-10-29 | 2005-07-26 | Transave Inc | Liberacion sostenida de anti - infecciosos. |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
EP2012750B1 (en) * | 2006-04-06 | 2018-02-21 | Insmed Incorporated | Methods for coacervation induced liposomal encapsulation and formulations thereof |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
CN106074461A (zh) | 2010-07-12 | 2016-11-09 | 赛利亚医药公司 | 通过氨基糖苷气雾给药治疗肺部感染 |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
CA2891487A1 (en) | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Stabilized vancomycin formulations |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
SG11201703434TA (en) * | 2014-10-27 | 2017-06-29 | Shenzhen Whalehouse Tech Company Ltd | Automatic warehouse control system and method |
CN105534961B (zh) * | 2015-12-30 | 2019-06-04 | 孙红娟 | 妥布霉素吸入溶液及其制备方法 |
CN105616345B (zh) * | 2016-03-01 | 2018-08-21 | 上海方予健康医药科技有限公司 | 一种妥布霉素吸入组合物及其制备方法和用途 |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
GB201815463D0 (en) * | 2018-09-24 | 2018-11-07 | Nerudia Ltd | Aerosol delivery device |
WO2020163416A1 (en) * | 2019-02-05 | 2020-08-13 | Mylan Inc | Devices and methods for tobramycin inhalation treatment |
CN111228243B (zh) * | 2019-12-24 | 2022-02-18 | 珠海亿胜生物制药有限公司 | 一种雾化吸入用妥布霉素脂质体及其制备方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL9401260A (nl) | 1993-11-12 | 1995-06-01 | Cornelis Johannes Maria Van Ri | Membraan voor microfiltratie, ultrafiltratie, gasscheiding en katalyse, werkwijze ter vervaardiging van een dergelijk membraan, mal ter vervaardiging van een dergelijk membraan, alsmede diverse scheidingssystemen omvattende een dergelijk membraan. |
US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
US5855564A (en) * | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
EP1161247A4 (en) * | 1998-12-17 | 2002-05-15 | Chiron Corp | Treatment method for severe chronic bronchitis (bronchiectasis) using an antibiotic aerosol |
AU3500901A (en) * | 2000-02-11 | 2001-08-20 | Medic Aid Ltd | Drug delivery apparatus |
NL1016030C1 (nl) * | 2000-08-28 | 2002-03-01 | Aquamarijn Holding B V | Sproei inrichting met een nozzleplaat, een nozzleplaat, alsmede werkwijzen ter vervaardiging en voor toepassing van een dergelijke nozzleplaat. |
EP1598059A1 (en) * | 2001-05-18 | 2005-11-23 | Chiron Corporation | Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
DE60210402T2 (de) * | 2001-05-18 | 2006-12-07 | Chiron Corp., Emeryville | System zur Abgabe einer Tobramycin-Formulierung |
SI1273292T1 (en) | 2001-07-02 | 2004-12-31 | Chiesi Farmaceutici S.P.A. | Optimised formulation of tobramycin for aerosolization |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
EP1458360B1 (en) * | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
EP1321159A1 (en) * | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
DK1673074T3 (da) | 2003-10-15 | 2007-05-07 | Pari Gmbh | Flydende præparat, indeholdende tobramycin |
DK1901749T3 (en) * | 2005-05-18 | 2016-10-24 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones AND USES THEREOF |
US20070116649A1 (en) * | 2005-09-29 | 2007-05-24 | Nektar Therapeutics | Antibiotic formulations, unit doses, kits, and methods |
US20090025713A1 (en) * | 2006-02-10 | 2009-01-29 | Pari Pharma Gmbh | Nebulised Antibiotics for Inhalation Therapy |
ES2611583T3 (es) | 2009-10-08 | 2017-05-09 | Shl Group Ab | Inhalador de gotitas de líquido dosificadas |
CN106074461A (zh) | 2010-07-12 | 2016-11-09 | 赛利亚医药公司 | 通过氨基糖苷气雾给药治疗肺部感染 |
-
2011
- 2011-07-08 CN CN201610456949.1A patent/CN106074461A/zh active Pending
- 2011-07-08 EP EP11738401.6A patent/EP2593110B1/en active Active
- 2011-07-08 US US13/178,930 patent/US8598131B2/en active Active
- 2011-07-08 CN CN201180034279XA patent/CN103052392A/zh active Pending
- 2011-07-08 KR KR1020137003587A patent/KR102012418B1/ko active IP Right Grant
- 2011-07-08 BR BR112013000921A patent/BR112013000921A2/pt not_active Application Discontinuation
- 2011-07-08 ES ES11738401T patent/ES2855159T3/es active Active
- 2011-07-08 MX MX2013000369A patent/MX336260B/es unknown
- 2011-07-08 JP JP2013518982A patent/JP6000946B2/ja active Active
- 2011-07-08 CA CA2803187A patent/CA2803187C/en active Active
- 2011-07-08 RU RU2013103534/15A patent/RU2597842C2/ru active
- 2011-07-08 WO PCT/EP2011/003405 patent/WO2012007130A1/en active Application Filing
- 2011-07-08 AU AU2011278693A patent/AU2011278693B2/en active Active
-
2013
- 2013-09-30 US US14/041,023 patent/US9067032B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8598131B2 (en) | 2013-12-03 |
AU2011278693A1 (en) | 2013-01-24 |
BR112013000921A2 (pt) | 2016-05-17 |
KR20130130689A (ko) | 2013-12-02 |
AU2011278693B2 (en) | 2015-02-19 |
KR102012418B1 (ko) | 2019-08-20 |
JP6000946B2 (ja) | 2016-10-05 |
RU2597842C2 (ru) | 2016-09-20 |
CA2803187A1 (en) | 2012-01-19 |
ES2855159T3 (es) | 2021-09-23 |
MX336260B (es) | 2016-01-13 |
CN106074461A (zh) | 2016-11-09 |
JP2013530248A (ja) | 2013-07-25 |
WO2012007130A1 (en) | 2012-01-19 |
EP2593110A1 (en) | 2013-05-22 |
CA2803187C (en) | 2019-05-14 |
US9067032B2 (en) | 2015-06-30 |
MX2013000369A (es) | 2013-02-15 |
EP2593110B1 (en) | 2021-01-06 |
US20120010162A1 (en) | 2012-01-12 |
RU2013103534A (ru) | 2014-08-20 |
US20140041654A1 (en) | 2014-02-13 |
CN103052392A (zh) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2855159T8 (es) | Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización | |
LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
HK1256490A1 (zh) | 用於治療病毒感染的嘧啶衍生物 | |
SMT201600325B (it) | Alifani, ciclofani, eterafani, eterofani, etero-eterafani e metalloceni sostituiti utili per il trattamento di infezioni da hcv | |
ES2898695T8 (es) | Derivados de benzoxaborol para el tratamiento de infecciones bacterianas | |
BR112015002524A2 (pt) | derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças. | |
BR112013012598A2 (pt) | composição de oligossacarídeos para tratar infecções agudas do trato respiratório | |
CO6930321A2 (es) | Curación de tejidos | |
BR112013012998A2 (pt) | compostos para tratar infecções por vírus sincicial respiratório | |
PL2696890T3 (pl) | Leczenie infekcji drobnoustrojowych | |
SMT201600059B (it) | Trattamento di infezioni da streptococco | |
CL2014001883A1 (es) | Compuestos y métodos para el tratamiento de las infecciones de candidiasis y aspergillus | |
CO6940377A2 (es) | Formulaciones de liofilizadas de fgf-18 | |
ZA201306342B (en) | The treatment of viral infections | |
BR112013011405A2 (pt) | composição farmacêutica para tratar infecções por hcv | |
DK2722053T3 (da) | Antibakterielt middel til behandling af infektionssygdomme af bakteriel oprindelse | |
CO6811849A2 (es) | Tratamiento de infecciones bacterianas | |
HK1198032A1 (en) | Nifuratel sulfoxide for use in the treatment of bacterial infections | |
TH1401003659A (th) | ไนฟูราเทลซัลฟอกไซด์สำหรับการใช้ในการรักษาการติดเชื้อแบคทีเรีย | |
GB201012168D0 (en) | Treatment of viral infections | |
GB201001821D0 (en) | Treatment of viral infections |